Medication info
Ezetimibe/Phenofibrate Tablets

Ezetimibe/Phenofibrate Tablets

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletFenofibrate›160mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
White circular film-coated tablet
Packaging
30 tablets/PTP[(10 tablets/PTP×3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202106924 · Approved 2021.10.14 · Insurance code 642004870

Summary

Main use
Adjunct to diet to reduce cholesterol and other lipids in mixed dyslipidemia
Who takes it
Adults
Adult dose
Adults: Take 1 tablet once daily immediately after a meal. This medicine must be used in combination with dietary therapy. Fenofibrate, one of the ingredients of this medicine, may be less well absorbed on an empty stomach; therefore, take it immediately after a meal. ○ Do not administer to patients with hepatic impairment. ○ Do not administer to patients with moderate to severe renal impairment (serum creatinine 2.5 mg/dL or higher). ○ Dose reduction is generally not required in older adults unless renal function is impaired. Patients taking ezetimibe and fenofibrate concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunct to diet to reduce cholesterol and other lipids in mixed dyslipidemia

View approved original text

This medication is used as an adjunct to lower total cholesterol, LDL cholesterol, apolipoprotein B, and non-high-density lipoprotein cholesterol levels in patients with mixed dyslipidemia. It helps improve blood lipid balance, primarily when used alongside a dietary regimen, which reduces the risk of cardiovascular diseases. This treatment aids in effectively managing patients' blood cholesterol levels.

How to take

Adult dose

Adults: Take 1 tablet once daily immediately after a meal. This medicine must be used in combination with dietary therapy. Fenofibrate, one of the ingredients of this medicine, may be less well absorbed on an empty stomach; therefore, take it immediately after a meal. ○ Do not administer to patients with hepatic impairment. ○ Do not administer to patients with moderate to severe renal impairment (serum creatinine 2.5 mg/dL or higher). ○ Dose reduction is generally not required in older adults unless renal function is impaired. Patients taking ezetimibe and fenofibrate concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication should not be administered to certain patients. For example, individuals with allergies to this medication or its ingredients should not take it. Patients with severe liver disease or persistently elevated liver enzyme levels without explanation should not receive this medication along with other specific lipid-lowering agents. Women who are pregnant or may become pregnant, as well as breastfeeding mothers, should not take this medication. Additionally, patients with impaired liver function, severe kidney impairment, or gallbladder disease should avoid this drug. Patients who have experienced phototoxic reactions during certain drug treatments, children, and patients with biliary cirrhosis or pancreatitis should also refrain from using this medication. Those with genetic issues such as lactose intolerance should not take this drug. Patients with slightly reduced kidney function, liver dysfunction, bleeding disorders, elderly patients, and others must use this medication cautiously. In particular, for cases of slightly impaired kidney function, the dosage may need to be reduced or the dosing interval extended. This medication may cause side effects such as headache, abdominal pain, diarrhea, myalgia, and fatigue. Furthermore, liver enzyme levels may increase, necessitating regular liver function tests. If muscle pain or weakness is felt, the patient should immediately inform their physician; in severe cases, the medication should be discontinued. This medication can interact with other lipid-lowering agents, anticoagulants, immunosuppressants, etc., so patients taking other medications must consult their doctor. Pregnant or breastfeeding women should avoid using this medication due to potential effects on the fetus during pregnancy, for which caution is advised. Children should not take this medication, and elderly patients should periodically check liver and kidney function while using it. In cases of overdose, there is no specific antidote, so appropriate treatment according to the symptoms is necessary, and it is vital to keep this medication out of the reach of children. This medication should be used in conjunction with dietary changes and lifestyle improvement, and regular blood tests and liver function tests should be conducted during treatment.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • joint pain
  • lower back pain
  • cough
  • chest pain
Show 93 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevated AST
  • elevated ALT
  • myalgia
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • erythema multiforme
  • elevated creatine phosphokinase
  • myopathy
  • rhabdomyolysis
  • elevated liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • pancreatitis
  • sensory disturbance
  • depression
  • cholelithiasis
  • cholecystitis
  • chest discomfort
  • swelling
  • weakness
  • systemic edema
  • diabetic neuropathy
  • tremors
  • upper abdominal pain
  • vomiting
  • gastritis
  • dry mouth
  • epigastric discomfort
  • belching
  • gastrointestinal disorder
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • runny nose
  • limb pain
  • anemia
  • splenomegaly
  • hyperhidrosis
  • pruritus
  • upper respiratory infection
  • conjunctival hyperemia
  • renal failure
  • liver dysfunction
  • increased serum creatinine
  • elevated blood pressure
  • increased blood urea
  • increased serum creatine phosphokinase
  • abnormal liver function tests
  • liver enlargement
  • cholestatic hepatitis
  • gallstones
  • rash
  • photosensitivity reaction
  • hair loss
  • malaise
  • hyperthermia
  • peripheral neuropathy
  • thromboembolic disease
  • elevated creatine kinase
  • muscle cramps
  • phototoxicity
  • photosensitivity reaction
  • gastrointestinal disorder
  • dyslipidemia
  • hemoglobin decrease
  • leukopenia
  • eosinophilia
  • elevated serum creatinine
  • eosinophilic pneumonia
  • ventricular arrhythmia
  • sexual dysfunction
  • weight gain
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute hypersensitivity reaction
  • DRESS syndrome
  • thrombocytopenia
  • agranulocytosis
  • myopathy
  • pulmonary embolism
  • deep vein thrombosis
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. Additionally, it should not be kept in excessively hot or cold places and is best stored at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White circular film-coated tablet

Package unit

30 tablets/PTP[(10 tablets/PTP×3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.